EMEA (Europe, Middle East and Africa) Ocular Drug Delivery Market Report 2017

December 2017 | 104 pages | ID: EB7BBC6964DEN
QYResearch

Abstracts

In this report, the EMEA Ocular Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Ocular Drug Delivery for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Ocular Drug Delivery market competition by top manufacturers/players, with Ocular Drug Delivery sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• OCULAR THERAPEUTIX, INC
• Alimera Sciences
• Allergan, Plc
• EyeGate Pharma
• Valeant Pharmaceuticals International, Inc
• Envisia Therapeutics
• Clearside Biomedical
• Graybug Vision Inc
• Taiwan Liposome Company
• Santen Pharmaceutical Co., Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• By Technology
• Ocular Insert
• Iontophoresis
• Intraocular Implants
• In Situ Gel & Punctal Plugs
• Others
• By Form
• Solution
• Suspension
• Emulsion
• Liposomes & Nanoparticles
• Ointment

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics
• Homecare Settings

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Ocular Drug Delivery Market Report 2017

1 OCULAR DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Ocular Drug Delivery
1.2 Classification of Ocular Drug Delivery
  1.2.1 EMEA Ocular Drug Delivery Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Ocular Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Ocular Insert
  1.2.4 Iontophoresis
  1.2.5 Intraocular Implants
  1.2.6 In Situ Gel & Punctal Plugs
  1.2.7 Others
1.3 EMEA Ocular Drug Delivery Market by Application/End Users
  1.3.1 EMEA Ocular Drug Delivery Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Ophthalmic Clinics
  1.3.5 Homecare Settings
1.4 EMEA Ocular Drug Delivery Market by Region
  1.4.1 EMEA Ocular Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Ocular Drug Delivery (2012-2022)
  1.5.1 EMEA Ocular Drug Delivery Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Ocular Drug Delivery Revenue and Growth Rate (2012-2022)

2 EMEA OCULAR DRUG DELIVERY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Ocular Drug Delivery Market Competition by Players/Manufacturers
  2.1.1 EMEA Ocular Drug Delivery Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Ocular Drug Delivery Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Ocular Drug Delivery Sale Price by Players (2012-2017)
2.2 EMEA Ocular Drug Delivery (Volume and Value) by Type/Product Category
  2.2.1 EMEA Ocular Drug Delivery Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Ocular Drug Delivery Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Ocular Drug Delivery Sale Price by Type (2012-2017)
2.3 EMEA Ocular Drug Delivery (Volume) by Application
2.4 EMEA Ocular Drug Delivery (Volume and Value) by Region
  2.4.1 EMEA Ocular Drug Delivery Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Ocular Drug Delivery Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Ocular Drug Delivery Sales Price by Region (2012-2017)

3 EUROPE OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Ocular Drug Delivery Sales and Value (2012-2017)
  3.1.1 Europe Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
3.2 Europe Ocular Drug Delivery Sales and Market Share by Type
3.3 Europe Ocular Drug Delivery Sales and Market Share by Application
3.4 Europe Ocular Drug Delivery Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Ocular Drug Delivery Sales Volume by Countries (2012-2017)
  3.4.2 Europe Ocular Drug Delivery Revenue by Countries (2012-2017)
  3.4.3 Germany Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.4 France Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.5 UK Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.6 Russia Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.7 Italy Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Ocular Drug Delivery Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Ocular Drug Delivery Sales and Value (2012-2017)
  4.1.1 Middle East Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
4.2 Middle East Ocular Drug Delivery Sales and Market Share by Type
4.3 Middle East Ocular Drug Delivery Sales and Market Share by Application
4.4 Middle East Ocular Drug Delivery Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Ocular Drug Delivery Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Ocular Drug Delivery Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  4.4.4 Israel Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  4.4.5 UAE Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  4.4.6 Iran Ocular Drug Delivery Sales and Growth Rate (2012-2017)

5 AFRICA OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Ocular Drug Delivery Sales and Value (2012-2017)
  5.1.1 Africa Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
5.2 Africa Ocular Drug Delivery Sales and Market Share by Type
5.3 Africa Ocular Drug Delivery Sales and Market Share by Application
5.4 Africa Ocular Drug Delivery Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Ocular Drug Delivery Sales Volume by Countries (2012-2017)
  5.4.2 Africa Ocular Drug Delivery Revenue by Countries (2012-2017)
  5.4.3 South Africa Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Ocular Drug Delivery Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Ocular Drug Delivery Sales and Growth Rate (2012-2017)

6 EMEA OCULAR DRUG DELIVERY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 OCULAR THERAPEUTIX, INC
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ocular Drug Delivery Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Alimera Sciences
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Ocular Drug Delivery Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Allergan, Plc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Ocular Drug Delivery Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 EyeGate Pharma
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Ocular Drug Delivery Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Valeant Pharmaceuticals International, Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Ocular Drug Delivery Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Envisia Therapeutics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Ocular Drug Delivery Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Clearside Biomedical
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Ocular Drug Delivery Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Graybug Vision Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Ocular Drug Delivery Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Taiwan Liposome Company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Ocular Drug Delivery Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Santen Pharmaceutical Co., Ltd
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Ocular Drug Delivery Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 OCULAR DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Ocular Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ocular Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ocular Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OCULAR DRUG DELIVERY MARKET FORECAST (2017-2022)

11.1 EMEA Ocular Drug Delivery Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Ocular Drug Delivery Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Ocular Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Ocular Drug Delivery Price and Trend Forecast (2017-2022)
11.2 EMEA Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Ocular Drug Delivery Sales Forecast by Type (2017-2022)
11.7 EMEA Ocular Drug Delivery Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Ocular Drug Delivery
Figure EMEA Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Ocular Drug Delivery Sales Volume Market Share by Type (Product Category) in 2016
Figure Ocular Insert Product Picture
Figure Iontophoresis Product Picture
Figure Intraocular Implants Product Picture
Figure In Situ Gel & Punctal Plugs Product Picture
Figure Others Product Picture
Figure EMEA Ocular Drug Delivery Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Ocular Drug Delivery by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Ophthalmic Clinics Examples
Table Key Downstream Customer in Ophthalmic Clinics
Figure Homecare Settings Examples
Table Key Downstream Customer in Homecare Settings
Figure EMEA Ocular Drug Delivery Market Size (Million USD) by Region (2012-2022)
Figure Europe Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Ocular Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Ocular Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure Africa Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Ocular Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Ocular Drug Delivery Sales Volume and Growth Rate (2012-2022)
Figure EMEA Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Ocular Drug Delivery Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Ocular Drug Delivery Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Ocular Drug Delivery Sales Share by Players (2012-2017)
Figure 2016 Ocular Drug Delivery Sales Share by Players
Figure 2017 Ocular Drug Delivery Sales Share by Players
Figure EMEA Ocular Drug Delivery Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Ocular Drug Delivery Revenue (Million USD) by Players (2012-2017)
Table EMEA Ocular Drug Delivery Revenue Share by Players (2012-2017)
Table 2016 EMEA Ocular Drug Delivery Revenue Share by Players
Table 2017 EMEA Ocular Drug Delivery Revenue Share by Players
Table EMEA Ocular Drug Delivery Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Ocular Drug Delivery Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Ocular Drug Delivery Sales Share by Type (2012-2017)
Figure Sales Market Share of Ocular Drug Delivery by Type (2012-2017)
Figure EMEA Ocular Drug Delivery Sales Market Share by Type (2012-2017)
Table EMEA Ocular Drug Delivery Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Ocular Drug Delivery Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ocular Drug Delivery by Type in 2016
Table EMEA Ocular Drug Delivery Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Ocular Drug Delivery Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Ocular Drug Delivery Sales Share by Application (2012-2017)
Figure Sales Market Share of Ocular Drug Delivery by Application (2012-2017)
Figure EMEA Ocular Drug Delivery Sales Market Share by Application in 2016
Table EMEA Ocular Drug Delivery Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Ocular Drug Delivery Sales Share by Region (2012-2017)
Figure Sales Market Share of Ocular Drug Delivery by Region (2012-2017)
Figure EMEA Ocular Drug Delivery Sales Market Share in 2016
Table EMEA Ocular Drug Delivery Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Ocular Drug Delivery Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Ocular Drug Delivery by Region (2012-2017)
Figure EMEA Ocular Drug Delivery Revenue Market Share Regions in 2016
Table EMEA Ocular Drug Delivery Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
Table Europe Ocular Drug Delivery Sales (K Doses) by Type (2012-2017)
Table Europe Ocular Drug Delivery Market Share by Type (2012-2017)
Figure Europe Ocular Drug Delivery Market Share by Type in 2016
Table Europe Ocular Drug Delivery Sales (K Doses) by Application (2012-2017)
Table Europe Ocular Drug Delivery Market Share by Application (2012-2017)
Figure Europe Ocular Drug Delivery Market Share by Application in 2016
Table Europe Ocular Drug Delivery Sales (K Doses) by Countries (2012-2017)
Table Europe Ocular Drug Delivery Sales Market Share by Countries (2012-2017)
Figure Europe Ocular Drug Delivery Sales Market Share by Countries (2012-2017)
Figure Europe Ocular Drug Delivery Sales Market Share by Countries in 2016
Table Europe Ocular Drug Delivery Revenue (Million USD) by Countries (2012-2017)
Table Europe Ocular Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Europe Ocular Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Europe Ocular Drug Delivery Revenue Market Share by Countries in 2016
Figure Germany Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure France Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Ocular Drug Delivery Sales (K Doses) by Type (2012-2017)
Table Middle East Ocular Drug Delivery Market Share by Type (2012-2017)
Figure Middle East Ocular Drug Delivery Market Share by Type (2012-2017)
Table Middle East Ocular Drug Delivery Sales (K Doses) by Applications (2012-2017)
Table Middle East Ocular Drug Delivery Market Share by Applications (2012-2017)
Figure Middle East Ocular Drug Delivery Sales Market Share by Application in 2016
Table Middle East Ocular Drug Delivery Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Ocular Drug Delivery Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Ocular Drug Delivery Sales Volume Market Share by Countries in 2016
Table Middle East Ocular Drug Delivery Revenue (Million USD) by Countries (2012-2017)
Table Middle East Ocular Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Middle East Ocular Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Middle East Ocular Drug Delivery Revenue Market Share by Countries in 2016
Figure Saudi Arabia Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Ocular Drug Delivery Sales (K Doses) by Type (2012-2017)
Table Africa Ocular Drug Delivery Sales Market Share by Type (2012-2017)
Figure Africa Ocular Drug Delivery Sales Market Share by Type (2012-2017)
Figure Africa Ocular Drug Delivery Sales Market Share by Type in 2016
Table Africa Ocular Drug Delivery Sales (K Doses) by Application (2012-2017)
Table Africa Ocular Drug Delivery Sales Market Share by Application (2012-2017)
Figure Africa Ocular Drug Delivery Sales Market Share by Application (2012-2017)
Table Africa Ocular Drug Delivery Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Ocular Drug Delivery Sales Market Share by Countries (2012-2017)
Figure Africa Ocular Drug Delivery Sales Market Share by Countries (2012-2017)
Figure Africa Ocular Drug Delivery Sales Market Share by Countries in 2016
Table Africa Ocular Drug Delivery Revenue (Million USD) by Countries (2012-2017)
Table Africa Ocular Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Africa Ocular Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Africa Ocular Drug Delivery Revenue Market Share by Countries in 2016
Figure South Africa Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Basic Information List
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Alimera Sciences Ocular Drug Delivery Basic Information List
Table Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Allergan, Plc Ocular Drug Delivery Basic Information List
Table Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table EyeGate Pharma Ocular Drug Delivery Basic Information List
Table EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Basic Information List
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Envisia Therapeutics Ocular Drug Delivery Basic Information List
Table Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Clearside Biomedical Ocular Drug Delivery Basic Information List
Table Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Graybug Vision Inc Ocular Drug Delivery Basic Information List
Table Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Taiwan Liposome Company Ocular Drug Delivery Basic Information List
Table Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Basic Information List
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ocular Drug Delivery
Figure Manufacturing Process Analysis of Ocular Drug Delivery
Figure Ocular Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2016
Table Major Buyers of Ocular Drug Delivery
Table Distributors/Traders List
Figure EMEA Ocular Drug Delivery Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Ocular Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Ocular Drug Delivery Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Ocular Drug Delivery Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Ocular Drug Delivery Sales Market Share Forecast by Region (2017-2022)
Table EMEA Ocular Drug Delivery Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Ocular Drug Delivery Revenue Market Share Forecast by Region (2017-2022)
Table Europe Ocular Drug Delivery Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Ocular Drug Delivery Sales Market Share Forecast by Countries (2017-2022)
Table Europe Ocular Drug Delivery Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Ocular Drug Delivery Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Ocular Drug Delivery Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Ocular Drug Delivery Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Ocular Drug Delivery Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Ocular Drug Delivery Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Ocular Drug Delivery Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Ocular Drug Delivery Sales Market Share Forecast by Countries (2017-2022)
Table Africa Ocular Drug Delivery Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Ocular Drug Delivery Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Ocular Drug Delivery Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Ocular Drug Delivery Sales Market Share Forecast by Type (2017-2022)
Table EMEA Ocular Drug Delivery Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Ocular Drug Delivery Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources